期刊
CLINICS IN DERMATOLOGY
卷 36, 期 1, 页码 14-20出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.clindermatol.2017.09.004
关键词
-
类别
The metabolic syndrome-otherwise called syndrome X, insulin resistance syndrome, Reaven syndrome, and the deadly quartet-is the name given to the aggregate of clinical conditions comprising central and abdominal obesity, systemic hypertension, insulin resistance (or type 2 diabetes mellitus), and atherogenic dyslipidemia. It is a prothrombotic and proinflammatory state characterized by increased inflammatory cytokine activity. In addition to inflammatory dennatoses such as psoriasis, lichen planus, and hidradenitis suppurativa, metabolic syndrome is also commonly associated with accelerated atherosclerotic cardiovascular disease, hyperuricemia/gout, chronic kidney disease, and obstructive sleep apnea. Current therapeutic options for metabolic syndrome are limited to individual treatments for hypertension, hyperglycemia, and hypertriglyceridemia, as well as dietary control measures and regular exercise. Crown Copyright (C) 2018 Published by Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据